Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,493 | Dovepress* | 5,970+ | 716 | 6,686 | |
| PubMed Central* | 523 | 116 | 639 | ||
| Totals | 6,493 | 832 | 7,325 | ||
| *Since 5 September 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar